相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction
Norbert Degousee et al.
CIRCULATION (2008)
Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation
Miao Wang et al.
CIRCULATION (2008)
Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation - Potential implications for cyclooxygenase-2 inhibition
Eric Arehart et al.
CIRCULATION RESEARCH (2008)
Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction
Jian-Yong Qian et al.
HYPERTENSION (2008)
Role of Dose Potency in the Prediction of Risk of Myocardial Infarction Associated With Nonsteroidal Anti-Inflammatory Drugs in the General Population
Luis Alberto Garcia Rodriguez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Current Pharmacological Treatment of Pulmonary Arterial Hypertension
Paschalis Steiropoulos et al.
CURRENT CLINICAL PHARMACOLOGY (2008)
Cyclooxygenases, prostanoids, and tumor progression
Man-Tzu Wang et al.
CANCER AND METASTASIS REVIEWS (2007)
Physiologic and pathophysiologic roles of lipid mediators in the kidney
C-M Hao et al.
KIDNEY INTERNATIONAL (2007)
Chemoprevention of colorectal cancer with cyclooxygenase-2 inhibitors: two steps forward, one step back
Monica M. Bertagnolli
LANCET ONCOLOGY (2007)
Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells
Hamida Hammad et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Peripheral formalin injection induces long-lasting increases in cyclooxygenase 1 expression by microglia in the spinal cord
Fei-Yu Zhang et al.
JOURNAL OF PAIN (2007)
Urine concentrating defect in prostaglandin EP1-deficient mice
Chris R. J. Kennedy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function
Marco Idzko et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Prostanoids in nociception and pain
Hanns Ulrich Zeilhofer
BIOCHEMICAL PHARMACOLOGY (2007)
Antagonism of the prostaglandin D-2 receptors DP1 and CRTH2 as an approach to treat allergic diseases
Roy Pettipher et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Deletion of microsomal prostaglandin E synthase-1 increases sensitivity to salt loading and angiotensin II infusion
Zhanjun Jia et al.
CIRCULATION RESEARCH (2006)
Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events - Meta-analysis of randomized trials
Jingjing Zhang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis
Miao Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Genetic model of selective COX2 inhibition reveals novel heterodimer signaling
Ying Yu et al.
NATURE MEDICINE (2006)
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
Y Cheng et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
T Grosser et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Characterization of a rabbit kidney prostaglandin F2α receptor exhibiting Gi-restricted signaling that inhibits water absorption in the collecting duct
RL Hébert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3
T Kunikata et al.
NATURE IMMUNOLOGY (2005)
Endogenous mechanisms of inhibition of platelet function.
RC Jin et al.
MICROCIRCULATION (2005)
Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure
TJ Aw et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Cyclooxygenases, thromboxane, and atherosclerosis -: Plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism
KM Egan et al.
CIRCULATION (2005)
Cyclooxygenase-2 and inflammation in atherosclerosis
MF Linton et al.
CURRENT OPINION IN PHARMACOLOGY (2004)
Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice
T Kobayashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation
AN Hata et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation
SJ Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
COX-2-derived prostacyclin confers atheroprotection on female mice
KM Egan et al.
SCIENCE (2004)
Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis
D Engblom et al.
NATURE NEUROSCIENCE (2003)
The isoprostanes: Unique products of arachidonic acid oxidation - A review
SS Fam et al.
CURRENT MEDICINAL CHEMISTRY (2003)
COX-2-dependent cardiac failure in Gh/tTG transgenic mice
ZB Zhang et al.
CIRCULATION RESEARCH (2003)
Developmental expression of functional cyclooxygenases in zebrafish
T Grosser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets
B Rocca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Role of prostacyclin in the cardiovascular response to thromboxane A2
Y Cheng et al.
SCIENCE (2002)
Roles of prostaglandin I2 and thromboxane A2 in cardiac ischemia-reperfusion injury -: A study using mice lacking their respective receptors
CY Xiao et al.
CIRCULATION (2001)
Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice
H Nakano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
COX in a crystal ball: current status and future promise of prostaglandin research
GA FitzGerald et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation
JE Fabre et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Platelet-active drugs - The relationships among dose, effectiveness, and side effects
C Patrono et al.
CHEST (2001)
Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation
BF McAdam et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Prostaglandin receptors: their role in regulating renal function
MD Breyer et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2000)